JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB201796

Biotinylation Kit / Biotin Conjugation Kit (Fast, Type B) - Lightning-Link®

3

(1 Review)

|

(25 Publications)

Biotinylation Kit / Biotin Conjugation Kit (Fast, Type B) - Lightning-Link® (ab201796) offers several standout features:

- Rapid Conjugation: achieve Biotin labeling in under 20 minutes with just 30 seconds of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: optimized to produce conjugates for assays where biotinylated protein is captured by streptavidin immobilized on a surface.
- Confidence: cited in over 20 publications.
3 Images
Conjugation - Biotinylation Kit / Biotin Conjugation Kit (Fast, Type B) - Lightning-Link® (AB201796)
  • Conjugation

PubMed

Parkash, Om, et al used Biotinylation Kit / Biotin Conjugation Kit (Fast, Type B) - Lightning-Link® (ab201796) as part of the development and evaluation of a biosensor based on screen-printed carbon electrodes (SPCEs) for the detection of dengue-specific immunoglobulin M (IgM) antibodies. They used the kit to conjugate Biotinylation Kit / Biotin to anti-Human IgM antibody for use in conjugation.
(A) Schematic diagram of the screen printed carbon electrode (SCPE)-based dengue IgM biosensor. The biosensor was constructed by sequentially adding optimised concentration of anti-human IgM capture antibody, blocking agent, human IgM antibody or serum sample, dengue antigen and detection antibody, with washing steps in between. Electrochemical signal was generated following addition of TMB substrate. (B) Comparison of various immobilisation techniques for the goat anti-human IgM capture antibody. NC : negative control consisting of a dengue IgM negative serum sample; PC : dengue IgM positive serum sample. (C) Field Emission Scanning Electron Microscopy (FESEM) surface images of (left panel) a bare carbon electrode and (right panel) a carbon electrode modified with an anti-human IgM antibody using the streptavidin/biotin immobilisation system. Both capture and detection antibodies were labeled using Lightning-Link® conjugation kits (ab201796 and ab102890).

Image from Parkash, Om, et al., Diagnostics (Basel), 11(1):33; doi: 10.3390/diagnostics11010033. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/

Schematic Diagram - Biotinylation Kit / Biotin Conjugation Kit (Fast, Type B) - Lightning-Link® (AB201796)
  • Schematic Diagram

Supplier Data

This illustration demonstrates a general procedure of how the Lightning-Link®(Fast) labeling technology enables the direct labeling of antibodies or proteins.

Simply pipette your antibody or biomolecule of choice into the vial of a lyophilized mixture containing the label of interest and incubate for just 15 minutes. Please see the ab201796 protocol booklet for more details.

Learn more about our Lightning-Link® conjugation kits here

Conjugation - Biotinylation Kit / Biotin Conjugation Kit (Fast, Type B) - Lightning-Link® (AB201796)
  • Conjugation

PubMed

Rackus, Darius G., et al used Biotinylation Kit / Biotin Conjugation Kit (Type B) - Lightning-Link® (ab201796) as part of examining digital microfluidics for detection a malaria biomarker. They used the kit to conjugate Biotinylation Kit / Biotin to anti-Plasmodium falciparum LDH antibody for use in pre-concentration by liquid intake by paper (P-CLIP).
DMF immunoassay for PfLDH. Comparison of mean signals obtained by traditional DMF-ELISA (black) and P-CLIP modified DMF-ELISA (grey) for concentrations below the limit of detection (7 ng mL-1) and limit of quantitation (70 ng mL-1) of the traditional DMF-ELISA. Error bars ± 1 std. dev. (n = 3).

Image from Rackus et al., Lab Chip., 17(13):2272-2280; doi: 10.1039/c7lc00440k. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/3.0/

Key facts

Product details

Biotinylation Kit / Biotin Conjugation Kit ab201796 uses a simple and quick process for biotinylation / biotin labeling of antibodies. It can also be used to conjugate other proteins or peptides. Learn about our antibody labeling kits and their advantages.

To conjugate an antibody to Biotin using this kit:
- add modifier to antibody and incubate for 15 mins
- add quencher and incubate for 5 mins
The conjugated antibody can be used immediately in WB, ELISA, IHC etc. No further purification is required and 100% of the antibody is recovered for use.

Learn about buffer compatibility below; for incompatible buffers and low antibody concentrations, use our rapid antibody purification and concentration kits. Use the FAQ to learn more about the technology, or about conjugating other proteins and peptides to Biotin.

The Type B Biotinylation Kit / Biotin Conjugation Kit is optimized to produce conjugates for assays in which the biotinylated protein is captured by streptavidin immobilized on a surface (e.g., plates, nitrocellulose, magnetic beads etc).

Use the Type A Biotinylation Kit / Biotin Conjugation Kit ab201795 to produce conjugates for assays in which a streptavidin-labeled detection reagent will be used.

Custom size conjugation kits up to 100 mg are available on demand. Please contact us to discuss your requirements.

This product is manufactured by Expedeon, an Abcam company, and was previously called Lightning-Link® Rapid Biotin Type B Labeling Kit. 371-0005 is the same as the 100 μg size. 371-0010 is the same as the 3 x 100 ug size. 371-0030 is the same as the 3 x 10 ug size. 371-0015 is the same as the 1 mg size.

Amount and volume of antibody for conjugation to Biotin

Kit size Recommended
amount of antibody1
Maximum
amount of antibody
Maximum antibody
volume2
3 x 10 μg 3 x 10 μg 3 x 20 μg 3 x 10 μL
100 μg 1 x 100 μg 1 x 200 μg 1 x 100 μL
3 x 100 μg 3 x 100 μg 3 x 200 μg 3 x 100 μL
1 x 1 mg 1 x 1 mg 1 x 2 mg 1 x 1 mL

1 Using the maximum amount of antibody may result in less labelling per antibody.

2 Ideal antibody concentration is 1 mg/ml. 0.5 - 1 mg/ml can be used if the maximum antibody volume is not exceeded. Antibodies > 2 mg/ml or < 0.5 mg/ml should be diluted /concentrated.

Buffer Requirements for Conjugation

Buffer should be pH 6.5-8.5.

Compatible buffer constituents
If a concentration is shown, then the constituent should be no more than the concentration shown. If several constituents are close to the limit of acceptable concentration, then this can inhibit conjugation.

50mM / 0.6% Tris1 0.1% BSA2 50% glycerol
0.1% sodium azide PBS Potassium phosphate
Sodium chloride HEPES Sucrose
Sodium citrate EDTA Trehalose

1 Tris buffered saline is almost always ≤ 50 mM / 0.6%
2 BSA can also interfere with the use of the conjugated antibody in tissue staining.

Incompatible buffer constituents

Thiomerosal Proclin Glycine
Arginine Glutathione DTT

If a constituent of the buffer containing your antibody or protein is not listed above, please contact us.

Only purified antibodies are suitable for use, ie. where other proteins, peptides, or amino acids are not present: antibodies in ascites fluid, serum or hybridoma culture media are incompatible.

Storing and handling conjugation kits

Lyophilized Lightning-Link® components are hygroscopic.

Kits are intentionally shipped at ambient temperature with silica gel to avoid exposure to moisture. Upon receipt, store the kit frozen and protect from moisture. Before opening the outer container, allow the lyophilized components to reach room temperature to minimize condensation.

What's included?

{ "values": { "3x10g": { "sellingSize": "3 x 10 µg", "publicAssetCode":"ab201796-3x10ug", "assetComponentDetails": [ { "size":"3 x 10 µg", "name":"Biotin (Type B) Conjugation Mix", "number":"AB201796-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201796-CMP03" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201796-CMP02" } ] }, "3x100g": { "sellingSize": "3 x 100 µg", "publicAssetCode":"ab201796-3x100ug", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201796-CMP02" }, { "size":"3 x 100 µg", "name":"Biotin (Type B) Conjugation Mix", "number":"AB201796-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201796-CMP03" } ] }, "1mg": { "sellingSize": "1 mg", "publicAssetCode":"ab201796-1mg", "assetComponentDetails": [ { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201796-CMP02" }, { "size":"1 x 1 mg", "name":"Biotin (Type B) Conjugation Mix", "number":"AB201796-CMP01" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201796-CMP03" } ] }, "100g": { "sellingSize": "100 µg", "publicAssetCode":"ab201796-100ug", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Biotin (Type B) Conjugation Mix", "number":"AB201796-CMP01", "productcode":"" }, { "size":"1 x 200 µL", "name":"Modifier reagent", "number":"AB201796-CMP03", "productcode":"" }, { "size":"1 x 200 µL", "name":"Quencher reagent", "number":"AB201796-CMP02", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Ambient - Cannot Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
-20°C

Product protocols

Target data

Publications (25)

Recent publications for all applications. Explore the full list and refine your search

The Journal of clinical investigation 135: PubMed40014401

2025

Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Saireudee Chaturantabut,Sydney Oliver,Dennie T Frederick,Jiwan J Kim,Foxy P Robinson,Alessandro Sinopoli,Tian-Yu Song,Yao He,Yuan-Chen Chang,Diego J Rodriguez,Liang Chang,Devishi Kesar,Meilani Ching,Ruvimbo Dzvurumi,Adel Atari,Yuen-Yi Tseng,Nabeel Bardeesy,William R Sellers

Journal of pharmaceutical analysis 14:100995 PubMed39850236

2025

Optical biosensing of monkeypox virus using novel recombinant silica-binding proteins for site-directed antibody immobilization.

Applications

Unspecified application

Species

Unspecified reactive species

Xixi Song,Ying Tao,Sumin Bian,Mohamad Sawan

ImmunoHorizons 8:729-739 PubMed39330967

2024

B Cells Influence Encephalitogenic T Cell Frequency to Myelin Oligodendrocyte Glycoprotein (MOG)38-49 during Full-length MOG Protein-Induced Demyelinating Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Michael A Faust,Lisa Gibbs,Juan M Oviedo,Douglas H Cornwall,Keke C Fairfax,Zemin Zhou,Tracey J Lamb,Brian D Evavold

Immunity 56:2570-2583.e6 PubMed37909039

2023

Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers.

Applications

Unspecified application

Species

Unspecified reactive species

Subir Biswas,Gunjan Mandal,Carmen M Anadon,Ricardo A Chaurio,Luis U Lopez-Bailon,Mate Z Nagy,Jessica A Mine,Kay Hänggi,Kimberly B Sprenger,Patrick Innamarato,Carly M Harro,John J Powers,Joseph Johnson,Bin Fang,Mostafa Eysha,Xiaolin Nan,Roger Li,Bradford A Perez,Tyler J Curiel,Xiaoqing Yu,Paulo C Rodriguez,Jose R Conejo-Garcia

The Journal of experimental medicine 220: PubMed37773046

2023

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Romina Marone,Emmanuelle Landmann,Anna Devaux,Rosalba Lepore,Denis Seyres,Jessica Zuin,Thomas Burgold,Corinne Engdahl,Giuseppina Capoferri,Alessandro Dell'Aglio,Clément Larrue,Federico Simonetta,Julia Rositzka,Manuel Rhiel,Geoffroy Andrieux,Danielle N Gallagher,Markus S Schröder,Amélie Wiederkehr,Alessandro Sinopoli,Valentin Do Sacramento,Anna Haydn,Laura Garcia-Prat,Christopher Divsalar,Anna Camus,Liwen Xu,Lorenza Bordoli,Torsten Schwede,Matthew Porteus,Jérôme Tamburini,Jacob E Corn,Toni Cathomen,Tatjana I Cornu,Stefanie Urlinger,Lukas T Jeker

Journal of translational medicine 21:367 PubMed37286997

2023

Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with Zirconium oxine for PET imaging.

Applications

Unspecified application

Species

Unspecified reactive species

Pamela Leland,Dhiraj Kumar,Sridhar Nimmagadda,Steven R Bauer,Raj K Puri,Bharat H Joshi

Microsystems & nanoengineering 9:10 PubMed36644334

2023

DropLab: an automated magnetic digital microfluidic platform for sample-to-answer point-of-care testing-development and application to quantitative immunodiagnostics.

Applications

Unspecified application

Species

Unspecified reactive species

Xuyang Hu,Xiangyu Gao,Songlin Chen,Jinhong Guo,Yi Zhang

Cancer discovery 13:216-243 PubMed36264161

2022

An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.

Applications

Unspecified application

Species

Unspecified reactive species

Leandro Venturutti,Martin A Rivas,Benedikt W Pelzer,Ruth Flümann,Julia Hansen,Ioannis Karagiannidis,Min Xia,Dylan R McNally,Yusuke Isshiki,Andrew Lytle,Matt Teater,Christopher R Chin,Cem Meydan,Gero Knittel,Edd Ricker,Christopher E Mason,Xiaofei Ye,Qiang Pan-Hammarström,Christian Steidl,David W Scott,Hans Christian Reinhardt,Alessandra B Pernis,Wendy Béguelin,Ari M Melnick

Nature biotechnology 41:212-221 PubMed36076083

2022

Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics.

Applications

Unspecified application

Species

Unspecified reactive species

Vadim Fedyuk,Nir Erez,Noa Furth,Olga Beresh,Ekaterina Andreishcheva,Abhijeet Shinde,Daniel Jones,Barak Bar Zakai,Yael Mavor,Tamar Peretz,Ayala Hubert,Jonathan E Cohen,Azzam Salah,Mark Temper,Albert Grinshpun,Myriam Maoz,Aviad Zick,Guy Ron,Efrat Shema

Physiological genomics 54:296-304 PubMed35759450

2022

MicroRNA cargo of extracellular vesicles released by skeletal muscle fibro-adipogenic progenitor cells is significantly altered with disuse atrophy and IL-1β deficiency.

Applications

Unspecified application

Species

Unspecified reactive species

Emily Parker,Bharati Mendhe,Ling Ruan,Brendan Marshall,Wenbo Zhi,Yutao Liu,Sadanand Fulzele,Yao Liang Tang,Meghan McGee-Lawrence,Tae Jin Lee,Ashok Sharma,Maribeth Johnson,Jie Chen,Mark W Hamrick
View all publications
websiteProtocolBooklet
en
websiteProtocolBooklet
zh

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com